Committees

Committee members play a critical role in providing FDLI with subject-matter and editorial advisory expertise.

2024 Committees

Program Committees

Advertising and Promotion Conference Planning Committee helps FDLI to provide timely and relevant programming regarding advertising and promotion trends, emerging issues, and policy developments. This conference is typically held in the fall.

  • Lauren Caroline Tadros Potter (Staff Liaison), FDLI
  • Dale Cooke (Co-Chair), PhillyCooke Consulting
  • Jae Kim (Co-Chair), DLA Piper LLP (US)
  • Katie Bond, Keller and Heckman LLP
  • Hannah R. Bornstein, Nixon Peabody LLP
  • Mark Gardner, Gardner Law, PLLC
  • Abraham Gitterman, Arnold & Porter LLP
  • Alan G. Minsk, Arnall Golden Gregory LLP
  • Anisa Mohanty, McDermott Will & Emery
  • Devaki Patel, Alston & Bird LLP
  • Nancy E. Taylor, Greenberg Traurig, LLP
  • Sara Wexler Koblitz, Hyman, Phelps & McNamara, PC
  • Heta Zaveri, Opus Regulatory, Inc.

Annual Conference Planning Committee helps plan and implement FDLI’s Annual Conference, the premier event of the food and drug law community. This conference is typically held in the spring.

  • Steven Leslie, FDLI (Staff Liaison)
  • Winston S. Kirton (Co-Chair), BakerHostetler 
  • Sarah H. Stec (Co-Chair), Johnson & Johnson
  • Laura Akowuah, CFSAN, FDA
  • Stacy Cline Amin, Morrison and Foerster, LLP
  • Kalah Auchincloss, Greenleaf Health, Inc.
  • Jennifer L. Bragg, Skadden, Arps, Slate, Meagher & Flom LLP
  • Shelby Buettner, Becton Dickinson (BD)
  • Lewis A. Grossman, American University Washington College of Law
  • Benneville (Ben) Haas, Latham & Watkins LLP
  • Dorothy K. Hatsukami, University of Minnesota Medical School
  • Maureen M Japha, Eli Lilly and Company
  • Elizabeth R. Jungman, CDER, FDA
  • Jeremiah J. Kelly, Venable LLP
  • Margaret Kober, CDER, FDA
  • Keith A. Matthews, Wiley Rein LLP
  • Sharon L. Mayl, DLA Piper LLP
  • Margaret (Mimi) Foster Riley, University of Virginia School of Law
  • Schevon Salmon, Otsuka America Pharmaceutical, Inc.
  • Sarah Sorscher, Center for Science in the Public Interest
  • Stuart TenHoor, Stuart TenHoor Legal Search
  • Rachel Turow, Walmart
  • Jessica L. Zeller, Edwards Lifesciences LLC
  • Lowell M. Zeta, Hogan Lovells US LLP

California Programs Planning Committee helps FDLI identify pertinent topics and develop programming to be offered in California.

  • Khara Minter (Staff Liaison), FDLI
  • Sophia Castillo, Keller and Heckman LLP
  • Michelle Davalos, Edwards Lifesciences LLC
  • Janet L. Michener Whipple, Validant
  • Kiera Murphy, Latham & Watkins LLP
  • Alexander J. Varond, Goodwin Procter LLP
  • Bianca N. Cardona Melendez, (Staff Liaison), FDLI
  • Nicholas Benetatos, Exponent, Inc.
  • M. Jason Brooke, Brooke & Associates
  • Charlene Cho, Johnson & Johnson
  • Kellie B. Combs, Ropes & Gray LLP
  • Mahnu Davar, Arnold & Porter LLP
  • Nidhi Gani, Archimedes Center for Medical Device Security, Northeastern University
  • James Fraser, Thompson Hine LLP
  • Carmine Jabri, Emma International
  • Jeremiah Kelly, Venable LLP
  • Marian J. Lee, McKesson Corporation
  • Elizabeth Richards, Latham & Watkins LLP
  • Cassie Scherer, Medtronic
  • Sara Shanti, Sheppard Mullin Richter & Hampton LLP
  • Lance L. Shea, Baker Hostetler
  • Eva Temkin, King & Spalding LLP
  • Stuart TenHoor, Stuart TenHoor Legal Search

Enforcement, Litigation, and Compliance Conference Planning Committee helps FDLI cover the latest trends and changes in enforcement and compliance. This conference is typically held in the fall.

  • Steven Leslie (Staff Liaison), FDLI
  • Maya P. Florence (Chair), Skadden, Arps, Slate, Meagher & Flom LLP
  • Kelly Bonner, Duane Morris LLP
  • Cathy L. Burgess, Alston & Bird LLP
  • Andrea Chamblee, George Washington University
  • John Claud, Hyman, Phelps & McNamara, PC
  • Aaron Danzig, Arnall Golden Gregory LLP
  • Lynne Ensor, Parexel International Corporation
  • James C. Fraser, Thompson Hine LLP
  • Mark Carlisle Levy, Eckert Seamans Cherin & Mellott, LLC
  • Perham Gorji, DLA Piper LLP (US)
  • Monica Groat, Latham & Watkins LLP
  • Steven A. Johnson, FDA Counsels
  • Peter V. Lindsay, Paul Hastings, LLP
  • Tim Lombardo, EAS Consulting Group
  • David Lonza, NSF International
  • Fred Medick, Genentech, Inc.
  • Anne K. Miller, Medtronic
  • Theodora McCormick, Epstein Becker & Green, PC
  • Clint Narver, US DOJ
  • Sonia W. Nath, Cooley LLP
  • Suzan Onel, Kleinfeld, Kaplan & Becker, LLP
  • Teresa Park, Covington & Burling LLP
  • George Toscano, Toscano Consulting Group (TCG)
  • Beth P. Weinman, Ropes & Gray LLP

FDLI at the Forefront Committee advises FDLI in formulating and implementing webinars about law, regulation and policy affecting food and dietary supplements, tobacco and nicotine, and medical products.

  • Khara Minter (Staff Liaison), FDLI
  • Paige Samson (Staff Liaison), FDLI
  • Lisa El-Shall, EAS Consulting Group
  • Mark Hendrickson, Leavitt Partners, LLC
  • Michael H. Hinckle, K&L Gates LLP
  • Eileen McMahon, Torys LLP
  • Karla L. Palmer, Hyman, Phelps & McNamara, PC
  • Lee Rosebush, BakerHostetler
  • Ronald Y. Rothstein, Winston & Strawn LLP
  • R. Trent Taylor, McGuireWoods LLP
  • Anne K. Walsh, Hyman, Phelps & McNamara, PC

Food Advertising, Labeling, and Litigation Conference Planning Committee helps FDLI to provide updates on the most pertinent aspects and trends in advertising, labeling, and litigation. This conference is typically held in the fall.

  • Bianca N. Cardona Melendez (Staff Liaison), FDLI
  • Benjamin P. Abel, Faegre Drinker Biddle & Reath LLP
  • Matthew G. Ball, K&L Gates LLP
  • Susan M. Bond, Kerry, Inc.
  • Veronica Colas, Hogan Lovells US LLP
  • Sam Dietle, Nestle USA, Inc.
  • Dale Joseph Giali, King & Spalding LLP
  • Jason W. Gordon, Reed Smith LLP
  • Shawn Obi, Winston & Strawn LLP
  • Evangelia C. Pelonis, Keller and Heckman LLP
  • Robert Roos, ACH Food Companies
  • Amaru Sanchez, Wiley LLP
  • Randal M. Shaheen, BakerHostetler

Food and Dietary Supplements Safety and Regulation Conference Planning Committee helps FDLI cover recent developments and looming challenges for product safety and regulation. The conference is typically held in the Spring.

  • Bianca Cardona Melendez (Staff Liason), FDLI
  • Deepti Kulkarni (Chair), Covington & Burling LLP
  • Andrea Bruce, Hogan Lovells US LLP
  • Laura Dias, Roquette America, Inc.
  • Kris DeAngelo, Michigan State University
  • Robert Durkin, Arnall Golden Gregory LLP
  • Andrea G. Ferrenz, Campbell Soup Company
  • Ernest Fung, Cardno ChemRisk
  • Phyllis Marquitz, Archer Daniels Midland Company
  • Lisa Navarro, Ramboll US
  • Omar Oyarzabal, EAS Consulting Group
  • Stuart M. Pape, Polsinelli PC
  • Laura Rich, Venable LLP
  • Christopher Van Gundy, Sheppard Mullin Richter & Hampton LLP
  • Jack Wenik, Epstein Becker & Green, PC

New to FDA Law and Regulation assists FDLI in creating educational programming and networking opportunities for those new to food and drug law.

  • Bianca N. Cardona Melendez (Staff Liaison), FDLI
  • Jana Caracciolo, GrayRobinson
  • Kathryn Culver, Latham & Watkins LLP
  • Jennifer A. Davidson, Kleinfeld, Kaplan & Becker, LLP
  • Laura S. Dona, Arnall Golden Gregory LLP
  • Daniela Drago, NDA Partners LLC
  • Yetunde Fadahunsi, Hogan Lovells US LLP
  • Jaclyn Fonteyne, Sidley Austin LLP
  • Colleen M. Heisey, Jones Day
  • Coleen Hill, Duane Morris LLP
  • Laurie Lenkel, FDA – OC
  • Michael Jordan, Troutman Pepper Hamilton Sanders LLP
  • Jeannie Mancheno, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
  • Rihana Miller, FDA – CDER
  • Kara Schoonover, Foley & Lardner LLP
  • Kelsey Tavares, DLA Piper LLP (US)
  • Rebecca Williams, Ropes & Gray LLP
  • Philip Won, Hyman, Phelps & McNamara, PC

Patient Organization Engagement Committee assists FDLI by creating innovative introductory course offerings for patient organizations.

  • Paige Samson (Staff Liaison), FDLI
  • Mitchell Berger, FDA – CBER
  • Trisha Devlin, Eli Lilly and Company
  • Devaveena Dey, FDA – CBER
  • Ryan Matthew Hohman, Friends of Cancer Research
  • Barbara Jones-Binns, Alston & Bird LLP
  • Susan S. Lee, Goodwin Procter LLP
  • Elizabeth Mulkey, Goodwin Procter LLP
  • Natalie Oehlers, Buchanan Ingersoll & Rooney PC
  • Amirala Pasha, Mayo Clinic
  • Cara Tenenbaum, Strathmore Health Strategy
  • James Valentine, Hyman, Phelps & McNamara, PC
  • David R. Zook, Faegre Drinker Biddle & Reath LLP
  • Kemi Asante, FDA
  • Kenita Barrow, Otsuka
  • Jennifer Bragg, Skadden
  • Nimi Chhina, BioMarin Pharmacetical Inc.
  • Carla Cartwright, Johnson & Johnson
  • Sandy Kalter, Medtronic
  • Dan Kracov, Arnold & Porter
  • Deepti Kulkarni, Covington & Burling
  • Marian Lee, McKesson Corporation 
  • Erika Lietzan, U. of Missouri-Columbia School of Law
  • Cynthia Meyer, Kleinfeld, Kaplan & Becker
  • Meredith Olearchik, Campbell Soup Company
  • Peter Pitts, Center for Medicine in the Public Interest
  • Bob Rhoades, Eliquent
  • Alex Varond, Goodwin Procter
  • Anne Walsh, Hyman Phelps

Publications Committees

Austern Writing Awards Committee fosters the next generation of professionals in the food and drug law field.

  • Paige Samson (Staff Liaison), FDLI
  • Sophia Gaulkin, Hyman, Phelps & McNamara, PC
  • Madeleine Giaquinto, Greenleaf Health, Inc.
  • Jennifer Kang, Otsuka America Pharmaceutical, Inc.
  • Matthew Piscitelli, Foley Hoag LLP
  • Jennifer Stonecipher Hill, Shook, Hardy & Bacon LLP

Food and Drug Law Journal Editorial Advisory Board provides peer review of manuscript submissions and advises on content for the Food and Drug Law Journal.

  • Paige Samson (Staff Liaison), FDLI
  • Meryl E. Bartlett, Latham & Watkins LLP
  • Laurie J. Beyranevand, Vermont Law School
  • James A. Boiani, Epstein Becker & Green, PC
  • Brigid Bondoc, Morrison & Foerster LLP.
  • Nathan A. Brown, Akin Gump Strauss Hauer & Feld LLP
  • Michelle Divelbiss, Covington & Burling LLP
  • Bridget C.E. Dooling, The Ohio State University Moritz College of Law
  • Jamie W. Gamerman, FDA – CDER
  • Peter Barton Hutt, Covington & Burling LLP
  • William M. Janssen, Charleston School of Law
  • John F. Johnson III, Shook, Hardy & Bacon LLP
  • Hannah Leibson, Arnold & Porter LLP
  • Geoffrey M. Levitt, Argenx
  • Markham C. Luke, FDA – CDER
  • Catherine A. Melfi, Omeros Corporation
  • Cynthia L. Meyer, Kleinfeld, Kaplan & Becker, LLP
  • Adam Muchmore, Penn State Law
  • Daniel Orr, Womble Bond Dickinson (US) LLP
  • Somnath Pal, St. John’s University College of Pharmacy
  • Tyler Morgan Scandalios, Arnold & Porter LLP
  • Shy Shorer, NIH, NCI, CCR
  • David Simon, Northeastern University School of Law
  • Eric Solowey, Parexel International Corporation
  • Emily Spiegel, University of Vermont
  • Thomas Tobin, Perkins Coie LLP 
  • Mark Tobolowsky, Hyman, Phelps & McNamara, PC
  • Andrew Wasson, Haug Partners LLP
  • Emily Wright, Pfizer Inc.

Publications and Academic Programs Committee helps identify areas for scholarly programming and provides high-level recommendations for all of FDLI’s publications, including updating essential references and generating content for new book resources.

  • Paige Samson (Staff Liaison), FDLI
  • Lewis A. Grossman, American University
  • Joanne Hawana, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
  • Cynthia Schnedar, Greenleaf Health, Inc.
  • Amy Speros, Latham & Watkins LLP

Update Magazine Peer Review Committee provides manuscript review and editorial feedback for Update magazine, electronic resources, and book chapters.

  • Paige Samson (Staff Liaison), FDLI
  • Lauren Farruggia, Goodwin Procter LLP
  • Jennifer Fulford, toXcel, LLC
  • Stephanie M. Haggerty, Pfizer Inc.
  • Rouget Frederic Henschel, Potomac Law Group
  • Ryan Knox, Harvard-MIT Center for Regulatory Science
  • Chad A. Landmon, Axinn, Veltrop & Harkrider LLP
  • Melissa B. Runsten, Debevoise & Plimpton, LLP
  • Emily Sachs, Latham & Watkins LLP
  • Marc Wagner, BakerHostetler

Product Area Committees

Cannabis-Derived Products Committee assists FDLI with developing content and identifying stakeholders to contribute to the discussion of cannabis-derived products in the federal regulatory space.

  • Lauren Caroline Tadros Potter (Staff Liaison), FDLI
  • Andrew J. Kline (Chair), Perkins Coie LLP
  • Kellsi Booth, Turning Point Brands, Inc.
  • Cheryl Dreyer, Kerry, Inc.
  • Pamela Nicole Epstein, Terpene Belt Processing, LLC
  • William Garvin, Buchanan Ingersoll & Rooney PC
  • Darin Hayakawa, Department of Health – Hawaii
  • Nicholas Markel, Toscano Consulting Group (TCG)
  • Lila McKinley, Connecticut Department of Consumer Protection
  • Deborah Miran, DMiran Consulting
  • Evelina Norwinski, Arnold & Porter LLP
  • Jarred Reiling, DLA Piper LLP (US)
  • Agustin Rodriguez, Troutman Pepper Hamilton Sanders LLP
  • Daniel Charles Rubenstein, Steptoe LLP
  • Frederick A. Stearns, Keller and Heckman LLP
  • Brian Yagi, Johns Hopkins University
  • Zach Zalewski, U.S. Pharmacopeia

Medical Products Committee helps FDLI provide programming to meet the needs of the medical products community.

  • Lauren Caroline Tadros Potter (Staff Liaison), FDLI
  • Sangeeta Abraham, Exponent, Inc.
  • M. Jason Brooke, Brooke & Associates
  • Elizabeth Guo, FDA – OC
  • Ralph F. Hall, University of Minnesota
  • Krista Hessler Carver, Covington & Burling LLP
  • Jeremiah J. Kelly, Venable LLP
  • Maarika Kimbrell, Morgan, Lewis & Bockius LLP
  • Brian J. Malkin, TEVA Pharmaceuticals USA, Inc.
  • Jewell Martin, BioMarin Pharmaceutical Inc.
  • Jason Mercer, Facet Life Sciences
  • Son Nguyen, Cooley LLP
  • Joshua M. Oyster, Ropes & Gray LLP
  • Teresa Reguly, Torys LLP
  • Elizabeth Richards, Latham & Watkins LLP
  • Javier Gonzalez Rivera, Arnold & Porter LLP
  • Lance L. Shea, BakerHostetler
  • Nicole Taylor Smith, Philips
  • Eva Temkin, King & Spalding LLP
  • James Wabby, AbbVie
  • Krupa Zachariah, Alston & Bird LLP

Tobacco and Nicotine Products Committee ensures that tobacco programs bring diverse stakeholders together to have high-level discussions on tobacco products regulation and policy.

  • Steven Leslie (Staff Liaison), FDLI
  • Jasjit Ahluwhalia, Brown University
  • Maham Akbar, Truth Initiative
  • Aruni Bhatnagar, University of Louisville
  • Shelly Blackwell, EAS Consulting Group
  • Brittani Cushman, Turning Point Brands, Inc.
  • Clifford E. Douglas, Foundation for a Smoke-Free World
  • Joe G. Gitchell, Pinney Associates, Inc.
  • Bryan M. Haynes, Troutman Pepper Hamilton Sanders LLP
  • Eshael Johnson, FDA-CTP
  • Rima Khoury, Fumari, Inc.
  • John L. Marshall, Altria Client Services LLC
  • Daniel P. McGee, Keller and Heckman LLP
  • Brian J. Miller, Johns Hopkins University
  • Gaye Montgomery, Black Buffalo Inc.
  • John O’Brien, RAI Service Company (RAISC) (Reynolds American Inc.)
  • Elizabeth Oestreich, Greenleaf Health, Inc.
  • Henry Roemer, Finger, Roemer, Brown & Mariani LLP
  • Sharyn Rutt, Philip Morris International
  • Barry Schaevitz, Fox Rothschild LLP
  • Jim Solyst, JMS Scientific Engagement
  • Mark J. Vaders, Womble Bond Dickinson (US) LLP
  • Jeffrey Weiss, Flagstaff Ventures
  • Tanya Wells, Vermont Department of Health

Task Forces

  • Lauren Caroline Tadros Potter (Staff Liaison), FDLI
  • Elizabeth Butterworth Stutts, Elizabeth Butterworth Stutts, Esq, PLLC
  • Patrick C. Gallagher, Duane Morris LLP
  • Grace Gowda, Merial, Inc.
  • Karl Nobert, Michael Best & Friedrich LLP
  • Jeannie M. Perron, Partner, Covington & Burling LLP

Governance Committees

Audit Committee oversees and evaluates the management’s control over financial reporting. This committee is led by and reports to the FDLI Board of Directors.

*This committee is not seeking applications for 2023

  • Hayley Carpenter (Staff Liaison), FDLI
  • Ricardo Carvajal (Chair), Hyman, Phelps & McNamara, PC
  • Cathy L. Burgess, Alston & Bird LLP
  • Neil P. Di Spirito, Brown Rudnick LLP
  • Jonathan A. Havens, Saul Ewing Arnstein & Lehr LLP
  • Stuart M. Pape, Polsinelli PC

Diversity, Equity, and Inclusion Advisory Committee advises FDLI on substantive and programmatic issues relevant to diversity, equity, and inclusion with a focus on promoting greater representation of Black professionals in the food and drug law community.

  • Benjamin Butz (Staff Liaison), FDLI
  • Elizabeth H. Anderson, Anderson & Associates, LLC 
  • Oluwaseun (Kemi) Asante, FDA – CDER
  • Kenita Barrow, Otsuka America Pharmaceutical, Inc.
  • Joseph D. Cohen, Porter Hedges LLP
  • L’Tonya Davis, FDA – OC
  • Kristina DiPano, McDermott Will & Emery
  • Javier Gonzalez Rivera, Arnold & Porter LLP
  • Hilary Hoffman, DLA Piper LLP (US)
  • Barbara Jones-Binns, Alston & Bird LLP
  • Kristin M. Kaplan, Shook, Hardy & Bacon LLP
  • Daniel Kracov, Arnold & Porter LLP
  • Tim Lombardo, EAS Consulting Group
  • Flora Chinyere Okereke, RAI Service Company (RAISC) (Reynolds American Inc.)
  • Mariam Sarwar, Crowell & Moring LLP
  • Sarah Thompson Schick, Reed Smith LLP
  • John (Barr) Weiner, FDA – OC
  • Madison Green, EMMA International

Finance Committee oversees FDLI’s financial affairs, including budget formulation and execution, and investment portfolio management. This committee is led by and reports to the FDLI Board of Directors.

  • Hayley Carpenter (Staff Liaison), FDLI
  • Melanie Gross (Chair), Genentech
  • Christina Anderson Mooney, Medtronic
  • Frederick R. Ball, Duane Morris LLP
  • Jeffrey N. Gibbs, Hyman, Phelps & McNamara, PC
  • Elizabeth Oestreich, Greenleaf Health, Inc.